Art

J-GLOBAL ID：202402219321661002   Reference number：24A0396086

HTLV-2 Enhances CD8+ T Cell-Mediated HIV-1 Inhibition and Reduces HIV-1 Integrated Proviral Load in People Living with HIV-1

HTLV-2はCD8+T細胞媒介HIV-1阻害を強化しHIV-1で生活する人々におけるHIV-1統合プロウイルス負荷を減少させる【JST・京大機械翻訳】

Author (24)： Abad-Fernandez Maria (Department of Microbiology & Immunology, UNC Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA) ,  Hernandez-Walias Francisco J. (Laboratory of Inmunovirologia, Ramon y Cajal Institute for Health Investigation (IRyCIS), University Hospital Ramon y Cajal, 28034 Madrid, Spain) ,  Hernandez-Walias Francisco J. (Department of Infectious Diseases, Ramon y Cajal Institute for Health Investigation (IRyCIS), University Hospital Ramon y Cajal, 28034 Madrid, Spain) ,  Hernandez-Walias Francisco J. (Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Institute of Health Carlos III (ISCIII), 28029 Madrid, Spain) ,  Leon Maria J. Ruiz de (Laboratory of Inmunovirologia, Ramon y Cajal Institute for Health Investigation (IRyCIS), University Hospital Ramon y Cajal, 28034 Madrid, Spain) ,  Leon Maria J. Ruiz de (Department of Infectious Diseases, Ramon y Cajal Institute for Health Investigation (IRyCIS), University Hospital Ramon y Cajal, 28034 Madrid, Spain) ,  Leon Maria J. Ruiz de (Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Institute of Health Carlos III (ISCIII), 28029 Madrid, Spain) ,  Vivancos Maria J. (Department of Infectious Diseases, Ramon y Cajal Institute for Health Investigation (IRyCIS), University Hospital Ramon y Cajal, 28034 Madrid, Spain) ,  Vivancos Maria J. (Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Institute of Health Carlos III (ISCIII), 28029 Madrid, Spain) ,  Perez-Elias Maria J. (Department of Infectious Diseases, Ramon y Cajal Institute for Health Investigation (IRyCIS), University Hospital Ramon y Cajal, 28034 Madrid, Spain) ,  Perez-Elias Maria J. (Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Institute of Health Carlos III (ISCIII), 28029 Madrid, Spain) ,  Moreno Ana (Department of Infectious Diseases, Ramon y Cajal Institute for Health Investigation (IRyCIS), University Hospital Ramon y Cajal, 28034 Madrid, Spain) ,  Moreno Ana (Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Institute of Health Carlos III (ISCIII), 28029 Madrid, Spain) ,  Casado Jose L. (Department of Infectious Diseases, Ramon y Cajal Institute for Health Investigation (IRyCIS), University Hospital Ramon y Cajal, 28034 Madrid, Spain) ,  Casado Jose L. (Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Institute of Health Carlos III (ISCIII), 28029 Madrid, Spain) ,  Quereda Carmen (Department of Infectious Diseases, Ramon y Cajal Institute for Health Investigation (IRyCIS), University Hospital Ramon y Cajal, 28034 Madrid, Spain) ,  Quereda Carmen (Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Institute of Health Carlos III (ISCIII), 28029 Madrid, Spain) ,  Dronda Fernando (Department of Infectious Diseases, Ramon y Cajal Institute for Health Investigation (IRyCIS), University Hospital Ramon y Cajal, 28034 Madrid, Spain) ,  Dronda Fernando (Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Institute of Health Carlos III (ISCIII), 28029 Madrid, Spain) ,  Moreno Santiago (Department of Infectious Diseases, Ramon y Cajal Institute for Health Investigation (IRyCIS), University Hospital Ramon y Cajal, 28034 Madrid, Spain) ,  Moreno Santiago (Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Institute of Health Carlos III (ISCIII), 28029 Madrid, Spain) ,  Vallejo Alejandro (Laboratory of Inmunovirologia, Ramon y Cajal Institute for Health Investigation (IRyCIS), University Hospital Ramon y Cajal, 28034 Madrid, Spain) ,  Vallejo Alejandro (Department of Infectious Diseases, Ramon y Cajal Institute for Health Investigation (IRyCIS), University Hospital Ramon y Cajal, 28034 Madrid, Spain) ,  Vallejo Alejandro (Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Institute of Health Carlos III (ISCIII), 28029 Madrid, Spain)
Material： Viruses (Web)
Volume： 14  Issue： 11  Page： 2472  Publication year： 2022 
JST Material Number： U7293A  ISSN： 1999-4915  Document type： Article
Article type： 原著論文  Country of issue： Switzerland (CHE)  Language： ENGLISH (EN)

Abstract/Point： People living with HIV-1 and H...

Thesaurus term： transaminase ,...
Semi thesaurus term： CD8陽性T細胞 ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=24A0396086&from=J-GLOBAL&jstjournalNo=U7293A") }}

Author keywords (6)： HTLV-2 ,  HIV-1 ,  cell-mediated cytotoxicity ,  HIV-1 reservoir ,  cell subsets ,  cytotoxic enzymes

JST classification (2)： Infectious immunity  (ED03030P) ,  Infectious diseases,parasitics diseases in general.  (GD01010H)

Reference (64)：

• Kalyanaraman, V.S.; Sarngadharan, M.G.; Robert-Guroff, M.; Miyoshi, I.; Blayney, D.; Golde, D.; Gallo, R.C. A New Subtype of Human T-Cell Leukemia Virus (HTLV-II) Associated with a T-Cell Variant of Hairy Cell Leukemia. Science 1982, 218, 571-573.
• Hall, W.W.; Ishak, R.; Zhu, S.W.; Novoa, P.; Eiraku, N.; Takahashi, H.; Ferreira, M.D.C.; Azevedo, V.; Ishak, M.O.G.; Ferreira, O.D.C.; et al. Human T Lymphotropic Virus Type II (HTLV-II): Epidemiology, Molecular Properties, and Clinical Features of Infection. J. Acquir. Immune Defic. Syndr. Hum. Retrovirology 1996, 13, S204-S214.
• Ishak, R.; Ishak, M.D.O.G.; Azevedo, V.N.; Machado, L.F.A.; Vallinoto, I.M.C.; Queiroz, M.A.F.; Costa, G.D.L.C.; Guerreiro, J.F.; Vallinoto, A.C.R. HTLV in South America: Origins of a silent ancient human infection. Virus Evol. 2020, 6, veaa053.
• Vandamme, A.-M.; Salemi, M.; Van Brussel, M.; Liu, H.-F.; Van Laethem, K.; Van Ranst, M.; Michels, L.; Desmyter, J.; Goubau, P. African Origin of Human T-Lymphotropic Virus Type 2 (HTLV-2) Supported by a Potential New HTLV-2d Subtype in Congolese Bambuti Efe Pygmies. J. Virol. 1998, 72, 4327-4340.
• Oliveira-Filho, A.B.; Araújo, A.P.S.; Souza, A.P.C.; Gomes, C.M.; Silva-Oliveira, G.C.; Martins, L.C.; Fischer, B.; Machado, L.F.A.; Vallinoto, A.C.R.; Ishak, R.; et al. Human T-lymphotropic virus 1 and 2 among people who used illicit drugs in the state of Pará, northern Brazil. Sci. Rep. 2019, 9, 14750.

Terms in the title (8)： HTLV ,  CD8+T細胞 ,  HIV-1 ,  阻害 ,  強化 ,  生活 ,  統合 ,  ウイルス負荷